当前位置:
X-MOL 学术
›
J. Natl. Cancer Inst.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Corrigendum.
Journal of the National Cancer Institute ( IF 10.3 ) Pub Date : 2019-11-01 , DOI: 10.1093/jnci/djy197
Journal of the National Cancer Institute ( IF 10.3 ) Pub Date : 2019-11-01 , DOI: 10.1093/jnci/djy197
Corrigendum to: M Lambertini, C Campbell, J Bines, et al. Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients, JNCI J Natl Cancer Inst (2019) 111(1): djy094; published online on June 5th, 2018. Co-author Jose Baselga has updated his disclosures in the Notes section of the manuscript.
中文翻译:
更正。
更正: M Lambertini,C Campbell,J Bines等。JNCI J Natl癌症研究所(2019)111(1):djy094; 该书于2018年6月5日在线发表。合著者何塞·巴塞尔加(Jose Baselga)已更新了手稿中“注释”部分的内容。
更新日期:2019-11-15
中文翻译:
更正。
更正: M Lambertini,C Campbell,J Bines等。JNCI J Natl癌症研究所(2019)111(1):djy094; 该书于2018年6月5日在线发表。合著者何塞·巴塞尔加(Jose Baselga)已更新了手稿中“注释”部分的内容。